PSP vs Sulforaphane for NK Cell Activity: A Research Comparison

Why this comparison

These two compounds come up constantly in conversations about natural killer (NK) cell support. They work through different mechanisms, have different research bases, and combine well. This article lays out what each one is, what the published research actually shows, and how to think about them.

A note on framing: this is informational content using structure/function language. We do not make therapeutic claims. The U.S. Food and Drug Administration has not evaluated structure/function statements for the prevention, diagnosis, or treatment of any disease. Consult a licensed physician before starting a supplement, especially if you are on prescription pharmaceuticals.

A 90-second NK cell primer

NK cells are innate-immune lymphocytes that recognize and lyse virus-infected and stressed cells without needing prior sensitization. They are first responders. The modern picture of NK biology, signaling, and clinical relevance is summarized in a 2024 review in Signal Transduction and Targeted Therapy ¹. NK-cell function declines with age — both fewer cells in circulation and reduced cytotoxic capacity per cell — as covered in a 2022 review focused specifically on NK aging ². Supplement strategies that support NK function are studied for their ability to compensate for this age-related decline.

Vitamin D status and regular exercise are foundational. A 2021 Frontiers in Immunology study found they were the two major determinants of NK-cell activity in their cohort ³. Get those right before optimizing the supplement layer.

Turkey tail PSP / PSK

What it is. A protein-bound polysaccharide fraction extracted from Trametes versicolor (turkey tail) mushroom. Two preparations dominate the research: PSK (polysaccharide-K, marketed as Krestin in Japan since the 1970s) and PSP (polysaccharopeptide, developed in China). The foundational 1984 description of Krestin ⁴ and a 2002 mechanism review ⁵ anchor the literature.

Mechanism. PSP/PSK is recognized by pattern-recognition receptors on innate-immune cells — primarily dectin-1, which binds beta-glucan structures. Engagement triggers a downstream cytokine cascade (IFN-γ, IL-12, TNF-α) that activates NK cells and other innate-immune populations. The activation is upstream of NK-cell cytotoxic-granule release.

Animal evidence. A 2012 mouse study showed PSK augmented docetaxel response in an immunocompetent murine host in a specifically immune-mediated way ⁶. The Japanese oncology-adjuvant research program over five decades represents the largest body of clinical work on any mushroom polysaccharide, though much of it is not indexed in PubMed and is in Japanese.

Human evidence. Substantial via the Japanese clinical-trial tradition. The 2002 review covers the picture in detail ⁵. Independent randomized trials in healthy adults specifically powered for immune-baseline endpoints are less common than the disease-context trials.

Dose. Japanese clinical protocols typically used 3 g/day. Daily-baseline supplementation doses for healthy adults are typically lower — 500 mg to 2 g — given that the goal is baseline support rather than disease-context immunostimulation.

Sulforaphane

What it is. An isothiocyanate. Specifically, the active compound produced when the precursor glucoraphanin (concentrated in broccoli sprouts and the Brassica family) meets the enzyme myrosinase. Dietary intake from cooked broccoli is much lower than from raw broccoli sprouts; supplemented stabilized glucoraphanin + active myrosinase provides more predictable dosing.

Mechanism — multiple axes. Sulforaphane is interesting because it works through several mechanisms that are relevant to immune function:

1. Nrf2 activation. Sulforaphane is one of the most-studied activators of the Nrf2 transcriptional pathway, which regulates a large set of antioxidant and detoxification genes. The 2021 Nutrients paper covered novel immunomodulatory effects of L-sulforaphane directly ⁷; the 2021 Molecules review covered the broader immune-enhancement literature ⁸.

2. NK-cell augmentation via cytokine signaling. A 2006 mouse study reported augmentation of NK-cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane through enhanced production of cytokines IL-2 and IFN-γ ⁹. This is the same general type of mechanism as PSP/PSK (cytokine-mediated NK activation) but through a different signaling pathway.

3. NKG2D-ligand induction on target cells. A 2015 Life Sciences paper described an interesting target-cell-side mechanism: sulforaphane induced NKG2D ligands in human cancer cell lines, increasing the target cells' visibility to NK-cell-mediated lysis ¹⁰. This is mechanistically different from PSP/PSK — sulforaphane is acting on the target cells in addition to the effector cells.

Human evidence. Substantial mechanism literature; growing translational research. Large-N randomized trials in healthy adults specifically powered for immune outcomes remain limited compared to the PSK clinical-trial base.

Dose. Sulforaphane absorption depends on the source. Supplemented forms typically use stabilized glucoraphanin with active myrosinase to produce sulforaphane in vivo. Doses in research range from 10 mg to 80 mg sulforaphane equivalents per day.

Head to head

A reasonable summary of the comparison:

Axis	Turkey tail PSP/PSK	Sulforaphane
Primary mechanism	Pattern-recognition receptor (dectin-1) → cytokine release → NK activation	Nrf2 activation + cytokine signaling + NKG2D-ligand induction
Acts on	Innate-immune effector cells (macrophages, dendritic cells, NK)	Both effector cells AND target cells
Depth of human clinical-trial base	Deep (Japanese oncology-adjuvant tradition)	Moderate (mechanism literature deeper than outcome trials)
Dietary source	Mushroom — not a routine dietary component	Broccoli sprouts (raw) — partially dietary-substitutable
Tolerability	Generally well-tolerated; GI sensitivity in some users	Generally well-tolerated; isothiocyanate-class flavor characteristic

They are not redundant. PSP/PSK acts on effector cells (the NK cells doing the killing); sulforaphane acts on both effector cells (via Nrf2 + cytokine signaling) and target cells (via NKG2D-ligand induction). A stack approach makes mechanistic sense.

How to think about this for daily supplementation

A few honest framings:

• For daily baseline support in healthy adults, modest doses of both make more sense than maximal doses of either. The high doses studied in Japanese oncology trials of PSK were context-specific; daily-baseline supplementation in healthy adults doesn't need to replicate those doses.
• For people with a serious health concern, the answer is to consult a physician — not to self-administer high-dose immune-modulator supplements alongside (or instead of) medical care.
• Foundational interventions come first. Sleep, vitamin D status, regular exercise, real food, alcohol moderation. The 2021 study showing vitamin D + exercise were the two major NK-activity determinants ³ is a useful reminder.
• Mushroom-polysaccharide quality varies. PSP/PSK is standardized by protein-bound polysaccharide content; many commercial products list only total mushroom-extract weight, which is not the same thing. Standardization matters.
• Sulforaphane source matters. Stabilized glucoraphanin + active myrosinase is the most predictable form; sprout-powder products without active myrosinase produce much less sulforaphane in vivo.

What this comparison does not settle

• It does not give you a head-to-head RCT. Direct PSP-vs-sulforaphane comparisons in healthy adults with NK-cell-function endpoints have not been published. We are reasoning from mechanism literature and individual-compound trials.
• It does not tell you whether the supplement-induced NK-activity changes translate to fewer infections or better real-world health outcomes. That would require very large outcome trials.
• It does not address dose-response in the stack. Adding both at half the individual doses is one defensible approach; adding both at full doses is another. The literature does not (yet) tell us which is preferred.

Where this fits in NK Prime

NK Prime is designed around the stack philosophy: turkey tail PSP, AHCC (another mushroom polysaccharide with its own clinical base), and sulforaphane all in one daily formula, plus vitamin D / K2 as the cofactor foundation. The pillar guide — Natural Killer Cells and Immune Optimization — covers each compound in more detail with full mechanism citation lists.